Both in Biotechnology
Scribe Therapeutics vs Kyverna Therapeutics
Over the past year SCTX returned −43.8% and KYTX returned −19.4%; their daily moves had a correlation of 0.32.
SCTX −43.8% KYTX −19.4%Growth of $1, one year, split-adjusted
| Metric | SCTX | KYTX |
|---|---|---|
| Price | $16.70 | $5.86 |
| Market cap | $316.2M | $362.1M |
| Today | +4.64% | +4.00% |
| 1 month | −27.5% | −14.4% |
| 6 months | — | −30.3% |
| Year to date | — | −37.7% |
| 1 year | — | −25.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $174.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 58.0% |
| Short % of float | 14.6% | 25.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).